World's Best Scientists 2026 revealed!
Antimicrobial Agents and Chemotherapy
H-index 57

Antimicrobial Agents and Chemotherapy

0066-4804

Published by: American Society for Microbiology

https://journals.asm.org/journal/aac

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 21 631 1108 54
Medicine 324 313 606 42

Additional Metrics

Number of Best Scientists*: 1284
Documents by Best Scientists*: 1610
Top 100 Ranked Scientists*: 48
SCIMAGO H-index: 299
SCIMAGO SJR: 1.431
Impact Factor: 4.5

Overview

Top Research Topics at Antimicrobial Agents and Chemotherapy?

The journal investigates areas of study like Microbiology, Antibacterial agent, Antibiotics, Pharmacology and Virology. While Antimicrobial Agents and Chemotherapy focused on Microbiology, it was also able to explore topics like Staphylococcus aureus, Bacteria and Escherichia coli. In it, researchers investigate the Escherichia coli study as part of research in the field of Biochemistry.

The Antibacterial agent works featured in Antimicrobial Agents and Chemotherapy incorporate elements from Ofloxacin, Ciprofloxacin, Minimum inhibitory concentration and Streptococcus pneumoniae. The studies on Antibiotics discussed can also contribute to research in the domains of Pseudomonas aeruginosa and Vancomycin. The tackled Pharmacology research is interrelated with In vivo which concerns subjects like In vitro.

Antimicrobial Agents and Chemotherapy connects research in Virology with the related topic of Molecular biology. It addresses concerns in the field of Pharmacokinetics by exploring it in line with topics in Gastroenterology which intersect with Surgery subjects. The work on Plasmid presented is anchored in Genetics and Gene.

  • Microbiology (51.52%)
  • Antibacterial agent (20.10%)
  • Antibiotics (18.62%)

What are the most cited papers published in the journal?

  • Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. (2257 citations)
  • A functional classification scheme for beta-lactamases and its correlation with molecular structure. (2176 citations)
  • In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing (1758 citations)

Research areas of the most cited articles at Antimicrobial Agents and Chemotherapy:

The journal articles investigate studies in Microbiology, Antibacterial agent, Antibiotics, Virology and Pharmacology. Specifically, studies on Drug resistance are prevalent in the Microbiology works discussed in the journal articles. While Antibacterial agent is the focus of the published articles, it also provides insights into the studies of Pseudomonas aeruginosa, Ciprofloxacin, Vancomycin and Antimicrobial.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Gene

The previous edition focused in particular on these issues:

The main points discussed in the journal deals with Microbiology, Pharmacokinetics, Internal medicine, Antibiotics and Pharmacology. The journal is focused mainly on Microbiology, particularly Antibiotic resistance. The work on Antibiotic resistance tackled in Antimicrobial Agents and Chemotherapy brings together disciplines like Multiple drug resistance, Drug resistance, Antimicrobial, Acinetobacter baumannii and Efflux.

While Pharmacokinetics is the focus of Antimicrobial Agents and Chemotherapy, it also provided insights into the studies of Tolerability, Adverse effect and Dosing. Most of the works presented in Antimicrobial Agents and Chemotherapy deals with Internal medicine but it intersects with the subject of Gastroenterology. Topics in Pharmacology explored in it were investigated in conjunction with research in Tuberculosis, Mycobacterium tuberculosis and In vivo.

The most cited articles from the last journal are:

  • Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2. (30 citations)
  • AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19. (21 citations)
  • Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection. (12 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Antimicrobial Agents and Chemotherapy (based on the number of publications) are:

  • Patrice Nordmann (249 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Laurent Poirel (200 papers) published 4 papers at the last edition, 2 less than at the previous edition,
  • Ronald N. Jones (161 papers) absent at the last edition,
  • Peter C. Appelbaum (160 papers) absent at the last edition,
  • David P. Nicolau (159 papers) published 8 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Antimicrobial Agents and Chemotherapy (based on the number of publications) are:

  • National Institutes of Health (538 papers) published 11 papers at the last edition, 2 more than at the previous edition,
  • French Institute of Health and Medical Research (458 papers) published 8 papers at the last edition, 6 less than at the previous edition,
  • Pasteur Institute (423 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Harvard University (393 papers) published 8 papers at the last edition, 4 less than at the previous edition,
  • Veterans Health Administration (371 papers) published 5 papers at the last edition, 10 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.38% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.29% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.68% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.43% of all publications and 61.60% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.

    Markus Hoffmann;Simon Schroeder;Simon Schroeder;Hannah Kleine-Weber;Marcel A. Müller;Marcel A. Müller

    (2020)
    545 Citations
  • Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.

    Miguel Angel Martinez

    (2020)
    455 Citations
  • Considerations for the Use of Phage Therapy in Clinical Practice

    (2022)
    376 Citations
  • Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147

    Gisele Peirano;Liang Chen;Barry N. Kreiswirth;Johann D. D. Pitout;Johann D. D. Pitout

    (2020)
    333 Citations
  • Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed

    (2022)
    272 Citations
  • A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.

    Yohei Doi;Masaya Hibino;Ryota Hase;Michiko Yamamoto

    (2020)
    230 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but looking for alternatives to traditional medical school, various online degrees offer flexible routes into nursing and advanced practice roles. Online direct entry MSN programs provide a fast track for individuals without a nursing background to earn a Master of Science in Nursing, enabling them to start rewarding careers in healthcare swiftly. online direct entry msn programs are designed with this goal in mind.

Nurses holding an RN license can advance their education through RN to BSN programs, with some offering no clinical requirements for added convenience. Programs like these help registered nurses enhance their qualifications and open doors to leadership or specialized roles. If you’re exploring your options, rn to bsn online programs provide a flexible way to gain a bachelor’s degree without disrupting your work schedule.

For further progression, many nurses consider bridging from a BSN to an MSN. Finding cost-effective and reputable programs can be challenging, but numerous resources highlight the bsn to msn options that balance affordability with quality education.

When comparing specific schools, choices like Capella versus Chamberlain offer distinct advantages and curricular structures for RN to BSN students. Understanding these differences can guide your decision to best fit your career goals. A helpful comparison can be found under capella rn to bsn vs chamberlain rn to bsn.

Best Scientists Contributing to This Journal

Recently Published Articles